Clinical Trial Update: SMS: Substrate Modification Study in Patients Getting an Implantable Cardioverter Defibrillator (ICD) [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating substrate modification in patients with ventricular tachycardia receiving an implantable cardioverter-defibrillator has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ventricular Tachycardia

Snippet

Sponsor: Medtronic Cardiac Rhythm and Heart Failure | Conditions: Tachycardia, Ventricular | Phase 4 | Status: COMPLETED